Many supplements are available to the general public for a limited time on our SuppleNet page.
VOLUME 59 1998 SUPPLEMENT 19
Articles
3 Introduction. Routine Use of
Atypical Antipsychotic Agents. George M. Simpson, M.D.
[PDF]
5 Common Treatment Goals of Antipsychotics:
Acute Treatment. Zafar A. Sharif, M.D.
[Abstract]
[PDF]
9 Pharmacologic Treatment
of First-Episode Schizophrenia:
Early Intervention Is Key to Outcome. John R. DeQuardo, M.D.
[Abstract]
[PDF]
18 The Routine Use of Atypical Antipsychotic Agents:
Maintenance Treatment. Bruce J. Kinon, M.D.
[Abstract]
[PDF]
23 Formulary Decisions and Health Economics. William M. Glazer, M.D.
[Abstract]
[PDF]
30 Management of Chronic
Psychotic Ambulatory Outpatients. Richard G. Petty, M.D.
[Abstract]
[PDF]
36 Long-Term Considerations After Switching Antipsychotics. Peter J. Weiden, M.D.; Ralph Aquila, M.D.;
Marianne Emanuel, R.N.; and Annette Zygmunt, M.S.
[Abstract]
[PDF]
50 Management of the
Agitated Elderly Patient in the Nursing Home:
The Role of the Atypical Antipsychotics. Sumer D. Verma, M.D.; Donald A. Davidoff, Ph.D.;
and Krishna K. Kambhampati, M.D.
[Abstract]
[PDF]
CME Section
56 Instructions and Posttest.
[PDF]
58 Registration and Evaluation.
[PDF]